Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Research & Development (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Research & Development for 11 consecutive years, with $52.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 18.3% year-over-year to $52.8 million, compared with a TTM value of $182.8 million through Dec 2025, up 14.46%, and an annual FY2025 reading of $182.8 million, up 14.46% over the prior year.
  • Research & Development was $52.8 million for Q4 2025 at Wave Life Sciences, up from $45.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $52.8 million in Q4 2025 and bottomed at $25.8 million in Q4 2021.
  • Average Research & Development over 5 years is $35.5 million, with a median of $33.4 million recorded in 2021.
  • The sharpest move saw Research & Development decreased 18.87% in 2021, then soared 31.02% in 2024.
  • Year by year, Research & Development stood at $25.8 million in 2021, then grew by 20.64% to $31.1 million in 2022, then increased by 9.64% to $34.1 million in 2023, then skyrocketed by 31.02% to $44.6 million in 2024, then grew by 18.3% to $52.8 million in 2025.
  • Business Quant data shows Research & Development for WVE at $52.8 million in Q4 2025, $45.9 million in Q3 2025, and $43.5 million in Q2 2025.